GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Duearity AB (OSTO:DEAR) » Definitions » Net Income From Continuing Operations

Duearity AB (OSTO:DEAR) Net Income From Continuing Operations : kr-30.85 Mil (TTM As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Duearity AB Net Income From Continuing Operations?

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Duearity AB's net income from continuing operations for the three months ended in Dec. 2023 was kr-13.08 Mil. Its net income from continuing operations for the trailing twelve months (TTM) ended in Dec. 2023 was kr-30.85 Mil.


Duearity AB Net Income From Continuing Operations Historical Data

The historical data trend for Duearity AB's Net Income From Continuing Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Duearity AB Net Income From Continuing Operations Chart

Duearity AB Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Net Income From Continuing Operations
-1.33 -15.36 -19.17 -25.76

Duearity AB Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Net Income From Continuing Operations Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -4.19 -3.65 -6.27 -7.86 -13.08

Duearity AB Net Income From Continuing Operations Calculation

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. It excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Net Income From Continuing Operations for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-30.85 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Duearity AB (OSTO:DEAR) Business Description

Industry
Traded in Other Exchanges
Address
Krusegrand 42D, Malmo, SWE, 212 25
Duearity AB is a medical technology company. It develops smallest and flexible products and services for tinnitus under the Tinearity brand.

Duearity AB (OSTO:DEAR) Headlines